RPL32P2

Across TCGA pan-cancer cohorts, RPL32P2 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RPL32P2’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RPL32P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P2 is over-expressed in tumor.

HNSC, LUSC, and STAD are the cancer types where RPL32P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.256	<.001	11	view →
LUSC	All	All	+0.385	<.001	6	view →
STAD	All	II,III,IV	+0.416	.001	4	view →
COAD	All	II,III,IV	+0.311	.005	4	view →
KIRC	Male	All	+0.198	.003	4	view →
KICH	All	IV	+0.545	.023	3	view →
LUAD	All	All	+0.214	.027	3	view →
CHOL	All	All	+0.960	.003	2	view →
UCEC	All	IV	+0.345	.033	2	view →
PRAD	All	All	+0.257	<.001	2	view →
LIHC	All	II,III,IV	+0.144	.032	2	view →
READ	All	II,III,IV	+0.390	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RPL32P2–HNSC

Open the HNSC breakdown →